The effect of recombinant human granulocyte-macrophage mediated through its triphosphate derivative Ara-CTP which colony-stimulating factor (GM-CSF) on the intracellular metabcompetes with normal nucleosides for the binding to DNA olism of cytosine arabinoside (Ara-C) was comparatively anapolymerase and for incorporation into the DNA. 
Introduction
Materials and methods Cytosine arabinoside (Ara-C) is one of the most active agents Cells and incubation procedures in the treatment of acute myeloid leukemia (AML) and provides the basis for the majority of currently applied treatment Bone marrow aspirates and peripheral blood (n = 6) were regimens.
1 Ara-C cytotoxicity is thought to be primarily obtained from 50 patients with newly diagnosed AML (median age 50.5 years, range and from eight healthy volunteers. FAB subtypes included two M0, seven M1, eight M2, Correspondence: W Hiddemann, Department of Hematology/ one M3, 14 M4, seven M4eo, nine M5, and two secondary
Oncology, Georg-August-University, Robert-Koch-Strasse 40, D-AML after myelodysplastic syndrome (MDS). In AML leukemic 37075 Göttingen, Germany Received 9 September 1996; accepted 2 January 1997 blasts had to comprise Ͼ70% of the total cell population.
Cells were subjected to Ficoll-Hypaque density gradient volume of 100 ml contained: 30 mg DNase-'activated' DNA, 10 mM dTTP, 10 mM dATP, 10 mM dGTP, 10 mM dCTP, 5 mM (1.007 g/cm 3 ) separation before further processing. Blast cells and NBMMC were cultured for 48 h in the absence or presMgCl 2 , 1 mM DTT, 50 mM Tris/HCl pH 7.4, 1 mCi dCTP (26 Ci/mmol; Amersham-Buchler). The samples were incuence of GM-CSF (100 U/ml) kindly provided by Behringwerke (Marburg, Germany) at a concentration of 1.5 × 10 6 /ml in bated for 15 min at 37°C. The incorporation of 3 H-dCMP into the DNA was determined using DE81 filter paper 30 ml of Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% heat-inactivated fetal calf serum (FCS), (Whatman). 21 For overall DNA polymerase measurements 20 ml of cell extract were incubated with reaction buffer glutamine (292 g/ml) and antibiotics (penicillin 60.2 mg/ml, streptomycin 133 g/ml) at 37°C in a 5% CO 2 atmosphere.
(30 min at 37°C). The reaction was carried out as already described, with dNTP concentrations of 250 mM. Throughout this investigation a single lot of fetal calf serum was used.
For thymidine and deoxycytidine kinase assays, 100 ml of reaction buffer (final concentrations: 100 mM Tris/HCl pH 8.0, 4.5 mM ATP, 5 mM MgEDTA, 0.2 mM 3 H-TdR (1 Ci/mmol), or 0.1 M 3 H-Ara-C (1 Ci/mmol, respectively) were added to
Cell extract preparation 100 ml of the cell extract and incubated at 37°C for 1 h. The reaction was terminated by incubating the samples at 100°C Cells were washed in 0.9% NaCl. For preparation of cell extracts, 10 7 cells were suspended in 100 l 50 mM Tris-HCl for 2 min. After precipitation of the proteins by centrifugation (2500 g for 3 min), 20 ml of the clarified reaction mixture was pH 7.4. Cell were lysed by freeze thawing of the suspension for three times. Cellular debris and unsolved proteins were spotted on DE81 anion exchange filter paper (Whatman), and washed twice with 0.1 mM ammoniumformiat (5 ml) and H 2 O pelleted by centrifugation at 12 000 g for 15 min at 4°C. The supernatant was assayed for enzyme activities and protein (5 ml), and once with 96% ethanol. Radioactivity of the phosphorylated nucleosides was counted in a LKB liquid scintilconcentration. 19 lation counter.
Determination of intracellular Ara-CTP levels

Statistical evaluation
The determination of the intracellular Ara-CTP levels was performed as previously described in detail. 20 In brief, after 12 h incubation with Ara-C, cells were washed twice in 0.9% Statistical analyses included the modified 2 test for groups NaCl, lysed in 200 ml 100 mM KH 2 PdtO 4 , 5 mM tetrabutylamof independent variables. Differences between median values monium phosphate, and 0.5% acetonitrile (pH 2.7, adjusted were calculated by the t-test. For all comparisons P values with H 3 PO 4 ) and subsequently centrifuged (1000 g for 5 min).
Ͻ0.05 were considered significant. The supernatant was removed and membrane-ultracentrifuged with Mini-cent-10 ultra centrifugation cartridges. Ara-CTP measurements were performed by an ion-pair HPLC method using a reverse-phase C18 column.
Results
Effect of GM-CSF on DNA synthesis and on Ara-C-3 H-thymidine and 3 H-Ara-C incorporation into the mediated inhibition of DNA synthesis DNA 3 H-thymidine (TdR) (2 Ci/mmol) and 3 H-Ara-C (30 Ci/mmol) Unstimulated median 3 H-TdR incorporation into the DNA was slightly lower in AML blasts as compared to NBMMC (2.15 were obtained from Amersham-Buchler, Braunschweig, Germany. After pre-incubation in the presence or absence of GMvs 3.09 pmol/10 5 cells). This difference was not statistically significant. From 35 AML specimens studied, 21 were found CSF 400 000 ( 3 H-TdR) and 800 000 ( 3 H-Ara-C) cells were plated in 24-well microtiter plates in a final volume of 2 ml to be responsive to GM-CSF as defined by an increase in 3 HTdR incorporation Ͼ1.5-fold over control values (median 1.57 IMDM.
3 H-TdR and 3 H-Ara-C and increasing amounts of unlabeled Ara-C (0.06-10 M final concentration) were added for vs 3.48 pmol/10 5 cells, P = 0.00004). All eight NBMMC samples were GM-CSF sensitive and revealed a GM-CSF-4 and 24 additional hours, respectively. Cells were harvested on DE81 filter paper (Whatman, UK) as previously induced increase in median 3 H-TdR incorporation from 3.09 to 7.4 pmol/10 5 cells (P = 0.00138). Restricting the comparadescribed. 21 tive evaluation to GM-CSF responsive cases only, AML blasts and NBMMC showed a similar increase of the 3 H-TdR uptake into the DNA after GM-CSF exposure (2.2-vs 2.6-fold, Enzyme assays Table 1 ) (Figure 1) .
Analysis of the Ara-C-mediated inhibition of DNA synthesis Overall DNA polymerase, DNA polymerase ␣, deoxycytidine kinase and thymidine kinase activity were determined as predemonstrates that the median inhibition of the 3 H-TdR incorporation into the DNA was significantly higher in AML blasts viously described. 13, 22, 23 In brief, for DNA polymerase ␣ determinations 20 ml of cell extract were incubated with 4 mg of as compared to NBMMC (76.5 vs 55.0%, P = 0.00015 at 0.05 M and 99.0 vs 96.0%, P = 0.02305 at 5.0 M Ara-C). protein A-Sepharose (Pharmacia, Freiburg, Germany), and 25 ml of purified Mab SJK 271-71 (0.73 mg/ml in phosphateNo differences were found for GM-CSF responsive and nonresponsive AML cases (median 75.5 vs 76.5% and 99 vs 99% buffered saline) for 2 h at 4°C. After washing of the immobilized immunocomplexes with 1 ml PBS and 1 ml buffer A at 0.05 and 5.0 M Ara-C, Table 2 ). GM-CSF pretreatment had no influence on the Ara-C-mediated inhibition of DNA syn-(5 mM MgCl 2 , 1 mM DTT, and 50 mM Tris/HCl pH 7.4) the reaction was started by the addition of reaction buffer (a final thesis in both AML blasts and NBMMC (Table 2) . After 48 h in vitro preincubation of the cells in the presence or absence of GM-CSF (100 U/ml) the DNA incorporation of 3 H-TdR was determined as described in Materials and methods. The results are expressed in median values (pmol per 100 000 cells). GM-CSF responsiveness is defined by a GM-CSF-induced increase in tritiated thymidine incorporation into the DNA Ͼ1.5-fold. GM-CSF priming significantly increases 3 H-TdR incorporation into the DNA in GM-CSF responsive AML blasts and in NBMMC.
Figure 2
Intracellular ara-CTP levels in AML blasts and NBMMC. GM-CSF responsive (̅) and non-responsive AML blasts (᭛) and Figure 1 Effect of GM-CSF on the 3 H-TdR incorporation into the NBMMC (᭺) were incubated for 12 h in increasing concentration of DNA. After 48 h in vitro preincubation of the cells in the presence Ara-C (1, 10, 100 M). The determination of the intracellular ara-CTP (+, filled symbols) or absence (−, empty symbols) of GM-CSF levels was performed as previously described by Schleyer et al. 20 The (100 U/ml) the DNA incorporation of tritiated thymidine was determbars represent the median values. ined as described in Materials and methods. Effect of GM-CSF on the intracellular ara-CTP levels Effect of GM-CSF on overall DNA polymerase and DNA polymerase ␣ activity Intracellular Ara-CTP levels were found to be 2-to 40-fold lower in NBMMC as compared to AML blasts at three different The effect of GM-CSF on the enzymatic activity of overall DNA polymerase (POL) and DNA polymerase ␣ (POLA) is Ara-C concentrations (median values: 18.7 vs 46.9, 48.0 vs 167.8 and 59.5 vs 337.5 ng/10 7 cells at 1, 10 and 100 M shown in Table 3 . In the absence of GM-CSF overall DNA polymerase activity was lower in AML blasts as compared to extracellular Ara-C, respectively, P Ͻ 0.01) (Figure 2 ). Following GM-CSF treatment, no effect on the intracellular Ara-CTP NBMMC (median 80.9 vs 96 pmol/min × mg, P = 0.036). GM- Ara-C-mediated inhibition of 3 H-TdR incorporation into the DNA was compared between AML blasts and NBMMC. Ara-C-mediated inhibition of DNA synthesis was determined by measurement of tritiated thymidine incorporation into the DNA in the presence of 0.05 and 5.0 M Ara-C. The results are given in percent of control samples which were incubated in the absence of Ara-C. GM-CSF responsiveness is defined by a GM-CSF-induced increase in tritiated thymidine incorporation into the DNA Ͼ1.5-fold. Ara-C-mediated inhibition of DNA synthesis is significantly lower in NBMMC when compared to AML blasts.
CSF treatment resulted in a signficant increase of overall DNA pmol/min × mg, P Ͼ 0.05). Both AML blasts and NBMMC showed a large range of DCK activity values (0.77-44.1 and polymerase activity in GM-CSF responsive AML cases from a median of 84.4 to 96.1 (P = 0.0001) and in NBMMC from a 4.6-27.9 pmol/min × mg). GM-CSF pretreatment resulted in only a slight increase of DCK activity in GM-CSF responding median of 96.7 to 189.8 pmol/min × mg (P = 0.014). GM-CSF non-responding AML blasts revealed no change in overall AML blasts (median 8.0 to 11.1 pmol/min × mg, P = 0.4589). Similarly, NBMMC (n = 6) showed no change in median DCK DNA polymerase activity (median 63.8 vs 67.8 pmol/min × mg, P = 0.4474). Increases in overall DNA polymerase activity activity in the presence of GM-CSF (19.5 vs 19 .5 pmol/min × mg). after GM-CSF were higher in NBMMC as compared to GM-CSF responsive AML blasts (median 1.5-vs 1.14-fold, Thymidine kinase (TK) activity was slightly higher in AML blasts as compared to NBMMC (median 6.4 vs 1.9 pmol/min P = 0.0016).
Spontaneous DNA polymerase ␣ activity was only slightly × mg, P = 0.0949). TK activity values were less variable than DCK activities in both AML blasts and NBMMC (range 1.3-higher in AML blasts than in NBMMC (median 3.1 vs 1.2 pmol/min × mg, P = 0.1874) ( Table 3) . After GM-CSF pretreat-56.0 and 1.4-5.6 pmol/min × mg). As depicted by Table 4 , median TK activity was significantly increased in NBMMC ment DNA polymerase ␣ activity significantly increased from a median of 3.45 to 5.2 pmol/min × mg in GM-CSF responsive after GM-CSF pretreatment (from median 1.92 to 3.57 pmol/min × mg, P = 0.039). However, GM-CSF responsive AML blasts and from a median of 1.2 to 2.2 pmol/min × mg in NBMMC (P = 0.00002 and P = 0.0156, respectively). Surand non-responsive AML blasts revealed only modest changes in TK activity after GM-CSF (6.4-11.2 and 4.25-4.5 pmol/min prisingly, DNA polymerase ␣ activity was also significantly enhanced by GM-CSF in AML blasts which showed GM-CSF × mg). induced increases of tritiated thymidine uptake into the DNA Ͻ1.5-fold (median 4.75 and 7.95 pmol/min × mg, P = 0.0783, Table 3 ).
Effect of GM-CSF on Ara-C incorporation into the DNA Effect of GM-CSF on thymidine kinase and deoxycytidine kinase activity of GM-CSF priming on the 3 H-Ara-C incorporation into the DNA at four different extracellular Ara-C concentrations.
3 HAra-C incorporation into the DNA was determined in 31 AML Table 4 summarizes the effect of GM-CSF priming on both TK and DCK. Median DCK activity was slightly lower in AML cases and in NBMMC from eight healthy volunteers. In the absence of GM-CSF Ara-C incorporation into the DNA was blasts as compared to NBMMC (median 9.65 vs 19 .5 565  Table 3 Effect of GM-CSF on overall DNA polymerase and DNA polymerase ␣ activity
AML blasts NBMMC
GM-CSF resp. GM-CSF non-resp. AML blasts and NBMMC were pre-incubated for 48 h with or without GM-CSF (100 U/ml). Cells were harvested and enzyme activities were determined as described (see Materials and methods). Enzyme activities of overall DNA polymerase and DNA polymerase ␣ are given in pmol 3 H-dCMP incorporated into 'activated' DNA per min per mg of protein. GM-CSF responsiveness is defined by a GM-CSF-induced increase in tritiated thymidine incorporation into the DNA Ͼ1.5-fold. GM-CSF pretreatment significantly enhanced overall DNA polymerase and DNA polymerase ␣ activity in GM-CSF responsive AML blasts and NBMMC. DNA polymerase ␣ activity was also increased in GM-CSF non-responsive AML blasts. a Overall DNA polymerase activity was significantly lower in AML blasts as compared to NBMMC (P Ͻ 0.05). b DNA polymerase ␣ activity was significantly higher in AML blasts as compared to NBMMC (P Ͻ 0.05).
Table 4
Effect of GM-CSF on thymidine and deoxycytidine kinase
AML blasts NBMMC
GM-CSF resp. GM-CSF non-resp. AML blasts and NBMMC were pre-incubated for 48 h in the presence or absence of GM-CSF (100 U/ml). Cells were harvested and enzyme activities were determined as described (see Materials and methods). Thymidine kinase (TK) and deoxycytidine kinase (DCK) activity is given in pmol phosphorylated Effect of GM-CSF on 3 H-Ara-C incorporation into the DNA. GM-CSF responsive (̅) and non-responsive AML blasts (᭛) and NBMMC (᭺) were pretreated in vitro for 48 h with (+, filled symbols) or without (−, empty symbols) GM-CSF (100 U/ml). Cells were incubated for an additional 24 h with increasing concentrations of Tables 5 and 6 ). In comparison, GM-CSF responsive AML blasts (n = 19) cellular Ara-C concentrations (0.06 and 0.16 M) the Ara-C DNA incorporation increased from a median of 0.038 to revealed 1.3-to 2.1-fold increases in 3 H-ara-C incorporation into the DNA with highest increases at low extracellular Ara-0.072 (P = 0.005) and from 0.095 to 0.147 pmol/10 5 cells
Figure 4
GM-CSF induced increases of the incorporation of Ara-C into the DNA at increasing extracellular Ara-C concentrations. GM-CSF responsive (̅) and non-responsive AML blasts (᭛) and NBMMC (᭺) were pretreated in vitro for 48 h with (filled symbols) or without (empty symbols) GM-CSF (100 U/ml). Cells were incubated for an additional 24 h with increasing concentrations of C concentrations ( 3 H-Ara-C DNA incorporation increased trations tested (median increases 1.71 at 0.06 M, 1.42 at 0.16 M, 1.59 to 1.0 M and 1.59-fold at 10 M Ara-C, from a median of 0.067-0.159 (median increase 2.08-fold) at 0.06 M, P = 0.00002; from 0.13 to 0.264 (median increase P Ͻ 0.05, Table 6 ). In GM-CSF responsive AML blasts 3 H-TdR incorporation 1.47-fold) at 0.16 M, P = 0.0003; from 0.422 to 0.787 (median increase 1.31-fold) at 1.0 M, P = 0.041, and from was enhanced by 2.2-fold at median. The respective effect on 3 H-Ara-C incorporation revealed a corresponding enhance-1.20 to 1.95 pmol/10 5 cells (median increase 1.26-fold) at 10 M Ara-C, P = 0.023). ment of the Ara-C uptake into the DNA at the lowest Ara-C concentration of 0.06 M (2.08-fold) while it decreased at GM-CSF non-responsive AML blasts (n = 12) showed no effect of GM-CSF pretreatment on 3 H-Ara-C incorporation into higher Ara-C levels to 1.47-fold at 0.16 M, 1.31-fold at 1.0 M and to 1.26-fold at 10 M. In comparison to NBMMC, the DNA at low Ara-C concentrations (0.089-0.066 (median increase 0.95-fold) and 0.113-0.112 pmol/10 5 cells (median 10 of 19 GM-CSF responsive AML specimens showed Ͼ2-fold increases in Ara-C incorporation into the DNA at the low Araincrease 1.0-fold) at 0.06 and 0.16 M Ara-C).
In contrast, 1.4-to 1.6-fold enhancements of 3 H-Ara-C C concentration of 0.06 M as compared to only one of eight cases in NBMMC (Figure 4) . At intermediate to high Ara-C incorporation into the DNA were observed at high extracellular Ara-C concentrations after GM-CSF pretreatment ( Ara-C incorporation into the DNA as compared to two of eight NBMMC cases (Figure 4 ). pmol/10 5 cells (median increase 1.37-fold) at 10 M Ara-C, P = 0.0005, Figure 3 and Tables 5 and 6 ).
In GM-CSF non-responding AML blasts no stimulation of 3 H-TdR incorporation was encountered. In these cases, howIn order to address the question whether GM-CSF priming selectively increases Ara-C incorporation into blast cell DNA ever, a concentration-dependent increase in 3 H-Ara-C uptake into the DNA was observed. Hence, the number of cases and whether this effect is related to an enhancement of proliferative activity, we compared the GM-CSF-induced showing Ͼ1.5-fold enhancements of the 3 H-Ara-C incorporation into the DNA increased from one of 12 cases at 0.06 M enhancements in 3 H-Ara-C incorporation into the DNA at four different extracellular Ara-C concentrations with GM-CSFto seven of 12 cases at 1.0 M Ara-C. As shown in Table 6 , GM-CSF induced enhancements of the 3 H-Ara-C incorporinduced enhancements of DNA synthesis in AML blasts and NBMMC.
ation into the DNA from a median of 0.95-fold at 0.06 M to a median of 1.63-fold at 1.0 M and 1.37-fold at 10 M In NBMMC, GM-CSF induced a median increase in DNA synthesis of 2.6-fold. The respective enhancement of 3 H-Araextracellular Ara-C. Hence, although GM-CSF had no effect on DNA synthesis in these cases it was still effective in C incorporation was substantially lower at all Ara-C concen- inducing an enhancement of the 3 H-Ara-C incorporation at (AML) in particular, has aimed to overcome two major limitations of current therapeutic modalities: (1) deaths from infecintermediate and high extracellular Ara-C concentrations (Table 6) .
tion by shortening the duration of treatment associated neutropenia; and (2) the limited sensitivity of leukemic blasts for These findings demonstrate a differential effect of GM-CSF on NBMMC and leukemic blasts as well as on DNA synthesis antileukemic agents by priming of blasts for subsequently or concomitantly applied cytostatic therapy. The latter approach and Ara-C incorporation, respectively. In NBMMC and GM-CSF responsive AML blasts, GM-CSF enhanced both DNA is supported by preclinical studies which indicate that hematopoietic growth factors like GM-CSF and IL-3 increase the synthesis and 3 H-Ara-C incorporation into the DNA. In these cases 3 H-Ara-C uptake appears more pronounced in AML percentage of AML blasts in S-phase, affect intracellular Ara-CTP/dCTP pool ratios, enhance DNA polymerase ␣ activity blasts suggesting a preferential effect of GM-CSF on these cells. In AML blasts that do not respond to GM-CSF with an and thereby increase the incorporation of Ara-C into the blast cell DNA. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In in vitro systems these effects were shown to increase of DNA synthesis on the other hand, GM-CSF still enhances 3 H-Ara-C incorporation into the DNA at high extratranslate into an increased cytotoxicity of Ara-C against clonogenic leukemic cells. Other investigations in contrast showed cellular Ara-C concentrations. a reduced susceptibility of leukemic blasts to antineoplastic agents after growth factor application, mostly due to an interference with mechanisms of apoptosis.
24,25
Discussion
In contrast to the extensive data about GM-CSF priming and its effect on the Ara-C metabolism in leukemic cells, little The introduction of hematopoietic growth factors into the treatment of acute leukemias, and acute myeloid leukemia information exists about the influence of hematopoietic 569 Table 6 Effect of GM-CSF on DNA synthesis and on Ara-C incorporation into the DNA
AML blasts NBMMC
GM-CSF resp. GM-CSF non-resp. AML blasts and NBMMC were pretreated in vitro for 48 h with or without GM-CSF (100 U/ml). Cells were incubated for an additional 24 h with increasing concentrations of growth factors on the metabolism of Ara-C in normal hematoas expressed by enhanced 3 H-TdR incorporation into DNA and increased DNA polymerase ␣ activity. In both cell types poietic cells and on the key enzymes responsible for this metabolism, such as DNA polymerase ␣ and deoxycytidine these effects translated into a subsequent enhancement of Ara-C incorporation into the DNA. In spite of a similar pattern of kinase. [14] [15] [16] [17] [18] Previous studies about the effect of GM-CSF on normal response to GM-CSF in NBMMC and AML blasts, substantial differences in quality and quantity of GM-CSF effects were hematopoietic precursor cells are hampered by small patient numbers and the restriction of analyses to few determinants observed. Hence, the median increase in DNA synthesis was significantly higher in NBMMC as compared to AML cells (2.6 only. The information available, however, suggests that normal and leukemic precursors may differ in cell cycle kinetics vs 1.7-fold). This difference was, however, not due to a lower overall responsiveness of AML blasts to GM-CSF but rather and/or intracellular Ara-C metabolism.
14-18 These differences may become more pronounced after stimulation with hematodue to the fact that 14 of 35 AML cases showed no effect of GM-CSF on DNA synthesis at all. When the comparative poietic growth factors and may explain that in vitro GM-CSF priming appears to enhance the cytotoxic effect of Ara-C evaluation was, therefore, restricted to GM-CSF responsive cases only, AML blasts and NBMMC showed a similar proagainst clonogenic leukemic blasts to a higher degree than against CFU-GM or CFU-GEMM.
9,10,14-17 liferative response to GM-CSF. This finding corresponds with the observation that the majority, but not all AML blast cells, The present study was performed to extend these investigations and to evaluate potential differences in the response express receptors for GM-CSF and show enhanced proliferation after GM-CSF exposure. [26] [27] [28] [29] Ara-CTP levels were not of NBMMC and leukemic blasts to GM-CSF in a more complex way. For this analysis the key enzymes of intracellular affected by GM-CSF priming in both NBMMC and AML blasts, suggesting that the GM-CSF-induced increase of the Ara-CAra-C metabolism and their intracellular products (Ara-CTP and Ara-C DNA incorporation) were determined with and mediated cytotoxicity is caused by an increase of the Ara-C incorporation into the DNA rather than by effects on intrawithout GM-CSF exposure in cells from eight healthy controls and from 50 patients with AML.
cellular Ara-CTP levels or Ara-CTP/dCTP ratios. Previous reports by Bhalla et al, [16] [17] [18] Karp et al 10 and Tanaka   30 Our data demonstrate that GM-CSF pretreatment of NBMMC and AML blasts results in increased DNA synthesis described significantly higher Ara-CTP/dCTP pool ratios in AML blasts as compared to NBMMC because of significantly
